Actively Recruiting
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2021-10-07
2500
Participants Needed
1
Research Sites
747 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
CONDITIONS
Official Title
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with cardiogenic shock treated at a tertiary care hospital.
You will not qualify if you...
- Age 17 years or younger.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Heart Center
Hamburg, Germany
Actively Recruiting
Research Team
B
Benedikt Schrage, MD
CONTACT
D
Dirk Westermann, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here